ESC Premium Access

Experience with empagliflozin: insights from practice.

Congress Presentation

About the speakers

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)
47 presentations
11 followers

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center, Dallas (United States of America)
20 presentations
0 follower

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
101 presentations
4 followers

Doctor Jacob Allan Udell

Women's College Hospital, Toronto (Canada)
9 presentations
0 follower

6 more presentations in this session

Introduction – Improving cardiovascular outcomes in patients with type 2 diabetes: where does the evidence lead us?

Speaker: Professor N. Marx (Aachen, DE)

Thumbnail

Managing cardiovascular outcomes in patients with type 2 diabetes – Where have we come from and where are we going?

Speaker: Professor D. McGuire (Dallas, US)

Thumbnail

Cardiovascular risk reduction with empagliflozin: exploring the evidence from EMPA-REG OUTCOME®.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Using empagliflozin in your patients with type 2 diabetes: considerations for daily patient care.

Speaker: Doctor J. Udell (Toronto, CA)

Thumbnail

Chair’s summary and audience Q&A.

Speaker: Professor N. Marx (Aachen, DE)

Thumbnail

Access the full session

Improving cardiovascular outcomes in patients with type 2 diabetes: where does the evidence lead us?

Speakers: Professor N. Marx, Professor D. McGuire, Professor F. Zannad, Doctor J. Udell, Professor N. Marx...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb